Private Ocean’s Emergent Biosolutions EBS Stock Holding History

Private Ocean’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-500	Closed	-$22K	–	643
2021 Q4	$22K	Buy	+500	New	+$22.6K	﹤0.01%	353
2018 Q1	–	Sell	-128	Closed	-$6K	–	430
2017 Q4	$6K	Buy	+128	New	+$5.39K	﹤0.01%	267

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Private Ocean's EBS Position: Q1 2022 in Review

Private Ocean sold out of Emergent Biosolutions (EBS) in Q1 2022, closing a stake of 500 shares — an estimated $22K sold.

Private Ocean first reported a position in EBS in Q4 2017 and held it in 2 quarters. The position peaked at $22K in Q4 2021. 255 funds tracked by Wall St. Rank hold EBS as of Q1 2022.

Private Ocean reported no remaining Emergent Biosolutions position as of Q1 2022 after selling out during the quarter.
Private Ocean sold 500 Emergent Biosolutions shares in Q1 2022, an estimated $22K.
Private Ocean first reported a position in Emergent Biosolutions in Q4 2017 and held it in 2 quarters.
Private Ocean's Emergent Biosolutions position peaked at $22K in Q4 2021.
255 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2022.

Based on Private Ocean's 13F filing for Q1 2022, filed 25 Apr 2022.